GOLGA2P7: A Potential Drug Target and Biomarker (G388152)

Target Name: GOLGA2P7

NCBI ID: G388152

GOLGA2P7

Other Name(s): GOLGA2 pseudogene 7

GOLGA2P7: A Potential Drug Target and Biomarker

GOLGA2P7, also known as GOLGA2 pseudogene 7, is a gene that encodes for a protein involved in the intracellular signaling pathway known as the GOLG-associated signaling pathway (GASP). This pathway plays a crucial role in the regulation of cell growth, apoptosis, and other cellular processes. The GASP pathway has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, the study of GOLGA2P7 and its potential drug targets or biomarkers has significant implications for the development of new therapeutic approaches.

GOLGA2P7 is a 21-kDa protein that is expressed in a variety of tissues, including brain, heart, skeletal muscles, and placenta. It is a member of the GOLG family, which includes proteins involved in the regulation of cell adhesion and signaling. The GOLG family is characterized by the presence of a unique nucleotide-binding oligomerization domain (NBD), which is responsible for the protein's intracellular signaling functions.

GOLGA2P7 is involved in the regulation of several cellular processes, including cell adhesion, migration, and survival. It has been shown to play a role in the regulation of neural cell migration, and is thus a potential drug target for neurodegenerative diseases. The GOLGA2P7 protein has also been shown to be involved in the regulation of cell apoptosis, which is a critical event in the regulation of cell numbers and the maintenance of tissue homeostasis.

In addition to its role in cellular signaling, GOLGA2P7 has also been shown to play a role in the regulation of cellular gene expression. Specifically, it has been shown to interact with the transcription factor, p53, and to regulate the expression of several genes, including the genes involved in cell adhesion and migration.

GOLGA2P7 has also been shown to be involved in the regulation of inflammation. Specifically, it has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha and IL-8. This suggests that GOLGA2P7 may be involved in the development of inflammatory diseases.

Despite its potential drug-target and biomarker properties, GOLGA2P7 has not yet been studied extensively, and much of its function and regulation remains unexplored. Therefore, further research is needed to fully understand the role of GOLGA2P7 in cellular signaling and the development of disease.

In conclusion, GOLGA2P7 is a gene that encodes for a protein involved in the intracellular signaling pathway known as the GOLG-associated signaling pathway. It has been shown to play a role in the regulation of several cellular processes, including cell adhesion, migration, and survival, as well as the regulation of cell apoptosis and gene expression. Further research is needed to fully understand the function and regulation of GOLGA2P7, and its potential as a drug target or biomarker.

Protein Name: GOLGA2 Pseudogene 7

The "GOLGA2P7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA2P7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets